SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,100,189 | -83.0% | 116,319 | -84.0% | 0.61% | -80.1% |
| Q2 2023 | $83,175,303 | +87.9% | 726,295 | +126.1% | 3.08% | +69.2% |
| Q1 2023 | $44,272,236 | +104.6% | 321,209 | +92.4% | 1.82% | +33.2% |
| Q4 2022 | $21,638,564 | +140.9% | 166,990 | +102.8% | 1.37% | +12.4% |
| Q4 2018 | $8,984,000 | -63.2% | 82,327 | -45.5% | 1.22% | -26.3% |
| Q3 2018 | $24,384,000 | +218.1% | 150,974 | +160.3% | 1.65% | +93.7% |
| Q2 2018 | $7,666,000 | -13.8% | 58,000 | -51.7% | 0.85% | -32.2% |
| Q1 2018 | $8,891,000 | +3.1% | 120,000 | -22.6% | 1.26% | +11.2% |
| Q4 2017 | $8,624,000 | – | 155,000 | – | 1.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |